INTRODUCTION {#S1}
============

Propagation of all sexually reproducing organisms depends upon the faithful development and function of reproductive organs. In *Drosophila*, oogenesis requires the coordinated differentiation of two distinct cell lineages, the germline and the gonadal somatic cells, to produce an egg. The germarium, where oogenesis initiates, contains both germline and somatic stem cells. Asymmetric cell division of germline stem cells (GSCs) within the germarium generates both a stem cell and a differentiated daughter cell, the cystoblast, which gives rise to a sixteen-cell interconnected cyst (for a review, see [@R37]). One of the sixteen cells in the cyst differentiates into an egg and the remaining cells become nurse cells ([@R26]; [@R59]). Somatic cell populations are intimately associated with germ cells during oogenesis: niche cells provide GSC maintenance signals and are tightly connected to GSCs via adhesion and gap junctions ([@R17]; [@R58]; [@R66]); inner sheath cells (ISCs) intermingle with the differentiating cystoblast and early dividing cysts to promote formation of the sixteen-cell cyst ([@R11]; [@R35]); follicle stem cells and their progeny, the follicle cells, surround each germline cyst as it buds off from the germarium and provide the maturing egg chamber with the positional cues needed for establishment of anterior-posterior and dorsal-ventral polarity of the embryo ([@R11]; [@R13]; [@R35]; [@R50]; [@R69]).

In addition to germline development, genomic integrity must be preserved to generate viable progeny. In *Drosophila*, transposable elements occupy nearly one third of the genome ([@R20]) and mobilization of even one of almost 150 transposon classes found can lead to defects in gametogenesis and sterility ([@R4]; [@R25]; [@R44]; [@R52]). Therefore, organisms have evolved small RNA-based defense systems to fight these elements ([@R33]). In *Drosophila*, both germline and somatic cells of the ovary rely on Piwi proteins and their 23-29 nt Piwi-interacting RNAs (piRNAs) to combat transposon activity ([@R1]; [@R19]; [@R24]; [@R29]; [@R45]; [@R55]; [@R61]). All three *Drosophila* Piwi proteins, Piwi, Aubergine (Aub) and Argonaute 3 (AGO3), are expressed in germline cells, whereas Piwi is also expressed in somatic gonadal cells. Interestingly, mutations in all known piRNA pathway components lead to oocyte and embryonic patterning defects and, ultimately, to sterility, believed to be an indirect consequence of transposon-induced genomic instability and activation of a DNA double-strand break checkpoint ([@R27]; [@R60]).

In contrast to other small RNAs, such as microRNAs and siRNAs, which are produced from double-stranded RNA precursors, piRNAs are derived from single-stranded RNA precursors, independently of the endonuclease Dicer ([@R61]). piRNA precursors originate from either active transposon transcripts or discrete genomic loci known as \`piRNA clusters\' ([@R2]). In *Drosophila*, piRNA clusters provide the primary source of antisense transposon transcripts, whereas active transposons predominantly provide sense transcripts ([@R2]; [@R21]). piRNAs associated with Piwi and Aub are mostly derived from piRNA clusters, mapping complementary to active transposons, whereas AGO3-bound piRNAs appear to be derived from the transposon itself ([@R2]). This relationship and a 10 nt overlap observed between sense and antisense piRNA pairs led to a model of piRNA amplification termed \`ping-pong\', in which 5′ ends of new piRNAs are generated through cleavage by the Piwi proteins themselves ([@R2]; [@R21]). In the *Drosophila* ovary, piRNA \`ping-pong\' is restricted to germline cells in which Piwi, Aub and AGO3 are present, although Piwi appears to be mostly dispensable for \`ping-pong\' amplification ([@R34]). In gonadal somatic cells, in which only Piwi is expressed, an alternative pathway functions. Here, single-stranded piRNA clusters or gene transcripts are processed to produce \`primary\' piRNAs that are directly loaded into Piwi, targeting active transposons or endogenous genes ([@R30]; [@R34]; [@R53]). The overlapping genetic requirements for Piwi in the germline and ovarian somatic cells suggest that Piwi may also engage primary piRNAs in the germline. Like Piwi, the germline-specific Aub engages piRNAs complementary to transposons, but has not been directly linked to primary piRNAs. Therefore, the precise relationship between primary piRNAs and \`ping-pong\' in the germline remains largely unknown.

The restriction of piRNA production and transposon control in gonadal tissues raises the question of how the piRNA biogenesis machinery has evolved specifically in the gonad. Here, we have identified Vreteno (Vret), a gonad-specific, Tudor domain-containing protein that functions specifically in the germline and somatic gonadal tissues during oogenesis. We show that Vret broadly regulates transposon levels and has an essential role in primary piRNA biogenesis, leaving \`ping-pong\' amplification intact.

MATERIALS AND METHODS {#S2}
=====================

*Drosophila* stocks {#S3}
-------------------

*Oregon R* and *w^1118^* flies served as controls. *vret^148-60^* and *vret^148-15^* were recovered from an ethyl methanesulfonate (EMS) mutagenesis screen and *vret^15^, vret^1B^, vret^70^, vret^39^, vret^46^* and *vret^49^* by non-complementation of *vret^148-15^.* Gal4 drivers used were: *c587-Gal4* ([@R66]); *nos-Gal4-VP16* ([@R63]); *traffic jam-Gal4* (Kyoto Stock Center); *otu-Gal4* ([@R49]); and *apterous-Gal4* (from J. Treisman, NYU School of Medicine, NY, USA). *gypsy-lacZ* was a gift from A. Bucheton (CNRS, Montpellier, France); *piwi^1^* and *piwi^2^* from H. Lin ([@R8]); *aub^HN2^* and *aub^QC42^* (from T. Schupbach, Princeton University, NJ, USA) and *UAS-aub-gfp* from P. Macdonald (University of Texas, TX, USA). All other stocks were from the Bloomington *Drosophila* Stock Center.

Identification, mapping and molecular cloning of *vret* {#S4}
-------------------------------------------------------

*vret* was mapped by male mitotic recombination between P15010 and P16672, a 23 kb region uncovered by the deficiency *Df(3R)Exel 6192* (Bloomington *Drosophila* Stock Center). Single-nucleotide polymorphism (SNP) meiotic mapping between the recombinant line P15010, *vret^1B^* and P16672 yielded a polymorphism in the *vret* gene that identified the *vret^1B^* mutation.

Immunofluorescence {#S5}
------------------

Adult ovaries were fixed and immunostained according to standard protocols. Wing imaginal discs immunostaining was performed as described ([@R48]). Imaging was performed on a Zeiss Meta 510 LSM confocal microscope. All samples were stained and imaged under identical conditions.

Vret antibody production and antibody reagents {#S6}
----------------------------------------------

Glutathione-[s]{.smallcaps}-transferase-*vret* cDNA (2-367 amino acids) was isolated in inclusion bodies for production of rabbit polyclonal anti-Vret (Covance). Other antibodies used were: rabbit anti-Vasa (Lehmann laboratory) at 1:5000; mouse 1B1 monoclonal supernatant (adducin-like) ([@R68]) at 1:20 and mouse anti-FasIII supernatant (7G10) at 1:10 (both from Developmental Studies Hybridoma Bank); rabbit anti-Orb ([@R38]) at 1:500; mouse anti-Myc Alexa555 conjugated-clone4A6 (Upstate) at 1:250, mouse anti-Myc 9E10 (AbCam) at 1:1000; rabbit anti-cleaved Caspase-3 (Asp175) (Cell Signaling Technology) at 1:100; chicken anti-GFP (AVES) at 1:500; rabbit anti-GFP (Invitrogen) at 1:1000; mouse anti-β-gal (Promega) at 1:1000; rabbit anti-Piwi at 1:5000, rabbit anti-Aub at 1:1000 and rabbit anti-AGO3 at 1:1000 (all three antibodies were provided by G. Hannon) ([@R2]); rabbit anti-Armi (a gift from W. Theurkauf) ([@R7]) at 1:10,000; mouse anti-α-tubulin (Sigma) at 1:50,000; mouse anti-β-tubulin (Sigma) at 1:2000; mouse anti-HA (Covance) at 1:200; mouse anti-Fibrillarin (EnCor Biotechnology) at 1:500; and DAPI (Roche) at 1:500 to visualize DNA. Alexa 488-conjugated Phalloidin (Molecular Probes) was used at 1:500. Secondary antibodies coupled to Alexa 488, Cy3 or Cy5 (Jackson ImmunoResearch Laboratories) were used at 1:500.

Clonal analysis {#S7}
---------------

*vret* germline clones were generated using the FLP/DFS (Flippase/Dominant Female Sterile) ([@R6]) or the FLP/GFP-marked clone ([@R67]) systems. For FLP/DFS clones, second (L2) and third (L3) instar larvae were heat shocked at 37°C for 2 hours on two consecutive days and *flp^122^*; *FRT82B, vret^148-60^*/*FRT82B, ovo^D^* adult females were fattened on yeast for 3 days for daily individual egg counts. For GFP-marked clones, L2 and L3 or 1- to 3-day-old adult flies of the genotype *flp^122^*; *FRT82B vret^148-60^*/*FRT82B, nlsGFP* were heat-shocked at 37°C for 2 hours on two consecutive days. Adult females were dissected 7 days after eclosion (when heat shock was carried out at larval stages) or 5 to 10 days after heat shock (when heat shock was carried out on 1- to 2-day-old adults).

Generation of transgenic flies {#S8}
------------------------------

Full-length *vret* coding sequence from expressed sequence tag (EST) LD38352 \[*Drosophila* Genomics Resource Center (DGRC)\] and *5x-myc* were amplified by PCR separately and subcloned into pGEM-7Zf (Promega) for sequencing. The *vret-myc* insert was then cloned into p*UASp* ([@R49]). Full-length *piwi* coding sequence from EST RE21038 (DGRC) was amplified by PCR, cloned and recombined into the pPHW vector. Both *pUASp-vret-myc* and *pUASp-HA-piwi* transgenes were introduced into the *Drosophila* genome using standard P-element-mediated transformation techniques ([@R51]). Transgene functionality was verified by complementation of sterility phenotype in the respective mutant backgrounds.

Microarray data analysis {#S9}
------------------------

Microarray analysis was performed in biological duplicates using total RNA extracted from *Drosophila* ovaries. The Affymetrix 3′-IVT Express Kit labeling protocol was applied followed by standardized hybridization and processing protocols using Affymetrix *Drosophila* 2.0 arrays. Transposable elements were identified on the arrays and their expression was analyzed in *vret^148-60^/vret^148-60^, piwi^1^/piwi^2^* and *aub^QC42^/aub^HN2^* ovaries after probe level summarization of the array intensities using a robust multichip average (RMA) algorithm. Each mutant was baseline-normalized to its corresponding heterozygote. Fifty-five significantly modulated probe set IDs corresponding to 52 unique transposable elements were identified in at least one of the three mutants analyzed, based on the statistical difference (*t*-test, *P*\<0.05, at alpha level, no multiple testing corrections applied) between homozygotes and heterozygotes for each genotype, combined with the minimum fold-change threshold (1.33, i.e. 33% change). All normalizations, statistical analyses, visualizations of hierarchical clustering results and Venn diagrams were performed in the Agilent GeneSpring GX11.5 platform. The array data is accessible from the NCBI Gene Expression Omnibus (GEO) public repository under accession number GSE30360.

Immunoprecipitation and western blot analysis {#S10}
---------------------------------------------

Ovaries were homogenized in NP-40 lysis buffer (150 mM NaCl, 50 mM Tris pH 8.0, 1% NP40) and the supernatant was incubated with anti-Myc tag agarose conjugate (Millipore) for 2 hours at 4°C and then washed in NP-40 lysis buffer. Samples were run on NuPAGE 4-12% Bis-Tris gradient gels (Invitrogen). Rabbit anti-Vret was used at 1:2000, mouse anti-β-Tubulin at 1:10,000, mouse anti-α-Tubulin at 1:50,000, rabbit anti-Piwi at 1:5000, rabbit anti-Aub at 1:1000, rabbit anti-AGO3 at 1:1000, rabbit anti-Armi at 1:10,000, rabbit anti-Vasa at 1:20,000, mouse anti-Myc at 1:1000, mouse anti-Fibrillarin at 1:500 and rabbit anti-Orb at 1:1000. HRP-conjugated secondary antibodies (Jackson ImmunoResearch) were used at 1:2000. An ECL-Western Blotting Detection Kit (Amersham) was used for visualization of horseradish peroxidase (HRP).

Subcellular fractionation {#S11}
-------------------------

Ovaries were homogenized in hypotonic lysis buffer (10 mM HEPES pH 7.9, 1.5 mM MgCl~2~, 10 mM KCl, 0.5 mM DTT) by 10-20 strokes of a glass Dounce homogenizer. The cell suspension obtained was incubated for 15 minutes on ice (homogenate fraction), centrifuged for 10 minutes at 1000 ***g*** and the supernatant was collected (cytosolic fraction). The remaining pellet was resuspended in high salt extraction buffer (20 mM HEPES pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl~2~, 0.2 mM EDTA, 0.5 mM DTT), centrifuged for 5 minutes at 20,000 ***g*** and supernatant was collected (nuclear fraction).

Small RNA cloning, sequencing and analysis {#S12}
------------------------------------------

Small RNAs were purified, cloned and sequenced as previously described ([@R2]). In brief, 18-29 nt small RNAs were size-selected on a 15% polyacrylamide vertical gel, cloned and sequenced on the Illumina Genome Analyzer II platform. Small RNA sequence reads were clipped of their 3′ linker sequence and identical sequences were collapsed. Reads were mapped, allowing for zero mismatches, against the *Drosophila melanogaster* genome release 5.0. Only reads mapping to the genome, excluding unassembled heterochromatin, were used for further analysis. Reads were normalized to the total number of 20-22 nt endogenous small interfering RNAs (endo-siRNAs) derived from all 3′UTR overlapping gene transcripts, as well as the esi-1 and esi-2 endo-siRNA clusters ([@R10]; [@R16]; [@R41]), as previously described ([@R34]). When mapping reads to the genome, no mismatches were allowed. When mapping to transposable element consensus sequences, up to three mismatches were allowed. When calculating \`ping-pong\' signal \[as described in Brennecke et al. ([@R3])\], piRNAs were mapped allowing for three mismatches. Small RNA libraries are deposited at Gene Expression Omnibus (accession number GSE30088, data sets GSM744629 and GSM744630).

Strand-specific RT-PCR and quantitative PCR {#S13}
-------------------------------------------

Total RNA was isolated from ovaries using TRIzol (Invitrogen) and treated with DNAfree reagent (Ambion). Expression levels of plus or minus strand-specific piRNA transcripts from clusters regions were measured as described in Klattenhoff et al. ([@R28]). Quantitative PCR (qPCR) reactions were performed using Power SYBR Green PCR Master Mix (Applied Biosystems) with the ABI Prism 7900 system (AME Bio-science). Reactions were performed without reverse transcriptase for each sample and did not produce significant signal.

RESULTS {#S14}
=======

*vreteno* is required for germline and ovarian soma development {#S15}
---------------------------------------------------------------

CG4771 (hereby known as *vreteno*, the Bulgarian word for \`wool-spinning spindle\', referring to its eggshell phenotype) was identified in a screen for maternal-effect mutations causing defects in oocyte polarity \[see Materials and methods in Staeva-Vieira (E. Staeva-Vieira, PhD thesis, New York University, 2003)\]. Point mutations were identified in the *vret* coding sequence for all eight alleles ([Fig. 1A](#F1){ref-type="fig"}; see Tables S1, S2 in the supplementary material). Both female and male *vret* mutants are sterile. Females mutant for strong *vret* alleles lay no eggs, whereas mutants for weaker alleles produce \`ventralized\' eggs: the chorionic appendages, a marker for dorsal fate, were either fused or failed to form completely, a phenotype referred to as \`spindle\' (see Table S1 in the supplementary material). Fertility was rescued in *vret* mutant females and males by a single copy of *vret* using a *UASp-vret-myc* transgene driven by the ubiquitously expressed *actin5C-Gal4* driver (see Table S3 in the supplementary material).

In *vret* mutant ovaries, both germline and somatic gonadal cell development is affected. In the strongest *vret* alleles (*vret^148-60^*, *vret^15^, vret^1B^*), the germarium was filled with germ cells that maintained a round spectrosome, suggesting failure of GSCs to differentiate ([Fig. 1B,D](#F1){ref-type="fig"}). Moreover, ISCs failed to associate with germ cells ([Fig. 1D](#F1){ref-type="fig"}; see Fig. S2B in the supplementary material). Weaker *vret* mutants (*vret^70^, vret^39^, vret^46^*) progressed to later stages of oogenesis but egg chambers were defective with abnormal nurse cell numbers and improper oocyte positioning ([Fig. 1C,E,F](#F1){ref-type="fig"}). In these mutants, follicle cells often failed to encapsulate egg chambers ([Fig. 1E](#F1){ref-type="fig"}), and occasionally formed disorganized multicellular layers ([Fig. 1G](#F1){ref-type="fig"}). Finally, *vret^49^and vret^148-15^* produced ventralized eggs but showed no defects in somatic gonadal cell patterning, germ cell differentiation or oocyte specification (see Table S1 in the supplementary material).

Vret is a novel Tudor protein {#S16}
-----------------------------

Vret contains two C-terminal Tudor domains ([Fig. 1A](#F1){ref-type="fig"}), conserved motifs composed of four β strands forming an aromatic cage known to recognize and bind symmetrically dimethylated arginine residues (sDMA) ([@R32]; [@R36]). Alignment of the two Tudor domains in Vret \[amino acids 376 to 422 (Vret tud1) and 581 to 626 (Vret tud2)\] with other Tudor domain proteins suggests that they form an N- and C-terminally \`extended\' structure (referred to as eTud) that closely resembles that of Tudor-SN (hSMN) and Tudor domain 11 of *Drosophila* Tudor protein (tud11) (see Fig. S1A-B in the supplementary material) ([@R14]; [@R32]; [@R56]). However, both Vret Tudor domains are unusual, as they do not have all of the four aromatic residues found in the canonical Tudor domain cage (see Fig. S1A in the supplementary material). Vret tud1 has three of the four aromatic residues, and Vret tud2 has only two. Three of the four Vret mis-sense mutations (*vret^39^, vret^49^* and *vret^148-15^*) map to the Tudor domains ([Fig. 1A](#F1){ref-type="fig"}), suggesting that both domains play an important role in Vret function. Indeed, the same glycine residue is mutated in the Vret tud1 and Vret tud2 domains in *vret^39^* and *vret^148-15^*, respectively, allowing a direct comparison of the relative role of the two domains. This glycine is highly conserved among Tudor domains and is likely to be important for holding the extended Tudor domain in a rigid structure ([@R32]). Interestingly, a glycine to glutamic acid change in Vret tud1 (*vret^39^*) exhibits a stronger phenotype than the same mutation in Vret tud2 (*vret^148-15^*). In particular, both point mutations in the Vret tud2 domain (*vret^49^* and *vret^148-15^*) do not affect somatic gonadal development, suggesting a qualitatively different role of the two domains in Vret function. A fourth mis-sense mutation (*vret^46^*) is located N-terminal to the two Tudor domains and identifies an additional region critical for Vret function.

![***vret* is a gonad-specific, Tudor-domain protein required for germline differentiation and ovarian soma organization.** (**A**) *vret* encodes a protein of 691 amino acids that includes two Tudor domains in the C terminus. *vret* stop codon mutations are indicated above and point mutations below the diagram of the protein. (**B**) In *vret^148-60^* heterozygotes, as in wild type, two to three GSCs with round spectrosomes are located at the anterior tip of the germarium (arrows), adjacent to the somatic niche, which is composed of terminal filaments, cap cells and ISCs (arrowheads). A cystoblast (CB) and a differentiating cyst (dashed line) are indicated. The germline is labeled with Vasa and somatic cell membranes and spectrosomes with 1B1. 1B1 staining in the GSC and CB marks single spectrosomes whereas in differentiating cysts it stains the fusome that connects the germ cells. (**C**) *vret^39^* heterozygote shows a normal egg chamber with an oocyte specified at the posterior, labeled by Orb, and surrounded by a somatic follicle cell epithelial layer. (**D**) Germarium filled with single, undifferentiated germ cells in *vret^148-60^* ovarioles. (**E**) Defective egg chambers with mislocalized oocytes and incomplete encapsulation by follicle cell layers in *vret^39^*, a weaker *vret* allele. (**F**) *vret^39^* mutant exhibits an abnormal number of nurse cells and a mislocalized oocyte. (**G**) Multilayered follicle cells partially envelope nurse cells in *vret^148-60^* mutants. (**H**) Vret protein is detected in an immunoblot of wild-type adult ovary and testis lysates. β-Tubulin was used as loading control. (**I**) Vret antibody shows specificity in ovarian lysates of *vret* mutant alleles. Vret full-length protein (around 80 kDa) is not detectable in *vret^148-60^*. A weak but specific band of smaller molecular weight is detected in *vret^148-60^*, consistent with molecular data. A lower, non-specific band is observed in all samples (arrow). α-Tubulin was used as loading control.](DEV069187F1){#F1}

Vret expression is gonad-specific and is required in both germline and soma for fertility {#S17}
-----------------------------------------------------------------------------------------

Antibodies directed against amino acids 2-367 of the Vret protein detected a discrete, 80 kDa band in extracts of wild-type ovaries and testes ([Fig. 1H](#F1){ref-type="fig"}). Vret expression was undetectable in fly carcass, in which gonads are absent, indicating that *vret* is exclusively expressed in gonadal tissue ([Fig. 1H](#F1){ref-type="fig"}). Full-length Vret protein was undetectable in strong mutants (*vret^148-60^*) and reduced in weaker alleles (*vret^39^* and *vret^46^*) ([Fig. 1I](#F1){ref-type="fig"}).

To distinguish between germline and somatic roles of Vret, we generated clones of homozygous *vret* cells in an otherwise *vret*/+ background using the FLP/FRT-GFP-mediated clonal technique. Removal of Vret from the germline resulted in the eggshell patterning spindle phenotype but did not affect earlier aspects of germ cell or somatic differentiation, indicating that *vret* is required autonomously in the germline for oocyte polarity ([Fig. 2A,B](#F2){ref-type="fig"}; see Table S2 in the supplementary material). Removal of Vret from somatic cells had no effect on oocyte specification or localization, or the morphology of the follicle cell epithelium ([Fig. 2B](#F2){ref-type="fig"}). However, clone size and cell-lineage specificity might have prevented us from detecting a soma-specific phenotype. We therefore expressed a *UASp-vret-myc* transgene under the control of tissue-specific Gal4 drivers. As expected, no rescue of the GSC differentiation phenotype was observed when Vret was expressed under the control of germline specific drivers, such as *nos-Gal4-VP16* and *otu-Gal4* (see Table S3 in the supplementary material). By contrast, somatic drivers, including *c587-Gal4*, which drives expression in the germarial somatic cells (cap, ISCs and follicle precursor cells), and *traffic jam-Gal4*, which in addition drives expression in all follicle cells, rescued *vret* germline differentiation defects and somatic defects (see Table S3 in the supplementary material; compare [Fig. 2C with 2D](#F2){ref-type="fig"}). Interestingly, *bab1-Gal4*, which expresses exclusively in terminal filament and cap cells, failed to rescue (see Table S3 in the supplementary material). Consistent with a role for Vret in early somatic cell lineages, we found that ISCs and accompanying somatic cells, which normally intermingle with germ cells, died in *vret* mutants as revealed by cleaved Caspase-3 expression (compare [Fig. 2E with 2F](#F2){ref-type="fig"}). Together these results suggest that the failure in germline differentiation observed in the absence of *vret* is due to defects in the association between germ cells and their somatic support cells. Thus, Vret exhibits different tissue requirements: expression of Vret in the somatic gonad is required for germ cell differentiation, somatic gonadal cell survival and morphology, whereas Vret expression in the germline is required for oocyte and embryo polarity. Only expressing *vret* ubiquitously using *actin5c-Gal4* rescued oogenesis to fertility (see Table S3 in the supplementary material).

![***vret* is required in both soma and germline for the production of progeny.** (**A**,**B**) *vret* is not required autonomously in germ cells for GSC differentiation. *vret^148-60^* mutant clones are marked by the absence of GFP. (A) A *vret* mutant GSC clone produced normally differentiating progeny (outlined), even 5-7 days after clone induction. (B) A budding *vret* germline cyst (dashed outline in germarium) shows a properly specified and localized oocyte (indicated by Orb staining). A stage 6 egg chamber with a large *vret* follicle cell clone (outlined) shows normal follicle cell morphology and polar cell specification (arrow), marked by anti-Fas III in addition to a properly specified oocyte. (**C**,**D**) Oogenesis defects are rescued in *vret^148-60^* mutants by expression of a *UASp-vret-myc* transgene using the somatic driver *c587-Gal4* (D), compared with *vret^148-60^* mutant ovaries in the absence of the driver (C). GFP expressed by a *UASp-gfp* transgene was used to mark *c587-Gal4* somatic cell populations. (**E**,**F**) Programmed cell death is detected by cleaved Caspase-3 staining in ovaries. Somatic (and possibly also germline) cells show increased Caspase-3 staining in *vret* mutant germaria (F) compared with heterozygotes (E).](DEV069187F2){#F2}

Vret is required for transposon silencing in germline and somatic ovarian cells {#S18}
-------------------------------------------------------------------------------

Our analysis points to striking parallels between Vret and genes affecting the *Drosophila* piRNA pathway. First, Vret contains two Tudor domains, recently shown to associate with Piwi proteins ([@R32]; [@R40]; [@R47]; [@R62]; [@R64]). Second, mutations in the two germline-specific *Drosophila* Piwi proteins Aub and AGO3 show oocyte polarity defects similar to those observed in *vret* germline clones ([@R30]; [@R65]). Finally, we found that mutations in both *flamenco* (*flam*), a piRNA cluster expressed exclusively in the ovarian soma, and *piwi* exhibited phenotypes similar to those observed in *vret* mutants, including defects in germ cell differentiation, somatic cell survival and follicle cell organization ([Fig. 3A-F](#F3){ref-type="fig"}). We therefore investigated whether *vret* has a role in regulating transposable elements activity. We analyzed the expression of the retroelement *gypsy* ([@R46]), which is active in the somatic gonad and is regulated by piRNAs of the *flam* cluster, using a *gypsy-lacZ* transgenic strain ([@R55]). While little β-galactosidase activity was observed in ovarian somatic cells of an otherwise *vret* heterozygous background ([Fig. 3G](#F3){ref-type="fig"}), *gypsy-lacZ* accumulated significantly and specifically in the somatic epithelium of *vret* mutant ovaries ([Fig. 3H](#F3){ref-type="fig"}). *ZAM* and *Idefix*, two other transposons regulated via the somatic Piwi/piRNA pathway ([@R12]), were also de-repressed in *vret* mutant ovaries as assayed by qPCR (data not shown).

We next tested whether *vret* was involved in global transposon regulation by performing microarray analysis. We found that most transposons contained in the *Drosophila* Genome 2.0 Array (Affymetrix), including those expressed specifically in the germline or somatic tissues of the ovary, were significantly de-repressed in *vret* homozygous mutants compared with heterozygotes ([Fig. 3J](#F3){ref-type="fig"}; see Table S4 in the supplementary material). We also compared *vret* mutant ovaries with those of *piwi* and *aub* mutants and found numerous transposons similarly regulated in the three mutants ([Fig. 3I,J](#F3){ref-type="fig"}; see Table S4 in the supplementary material). Piwi, like Vret, acts in both germline and somatic tissues of the gonad. Thus, similar elements were de-repressed in *vret* and *piwi* mutant ovaries, including *gypsy5, gtwin, tabor* and *ZAM*, elements known to be regulated specifically in somatic cells ([Fig. 3J](#F3){ref-type="fig"}; see Table S4 in the supplementary material). Furthermore, elements highly de-repressed in *aub* mutants were similarly de-repressed in *vret* mutants ([Fig. 3J](#F3){ref-type="fig"}). Our results are consistent with a role for Vret in transposon regulation in both germline and somatic tissues of the *Drosophila* gonad.

Piwi proteins localization and accumulation depend on Vret {#S19}
----------------------------------------------------------

In wild type, Aub and AGO3 are expressed exclusively in germline cells and localize to a perinuclear structure known as \`nuage\' in nurse cells ([@R23]; [@R30]; [@R31]). Piwi, expressed in both germline and somatic cells of the ovary, is predominantly nuclear ([@R2]; [@R9]). We therefore investigated whether the localization and accumulation of Piwi proteins were affected in *vret* mutants. We compared mutant and wild-type expression within the same tissue by removing *vret* specifically from germline and/or soma by clonal analysis (see Materials and methods). The nuclear localization and protein accumulation of Piwi was almost entirely abolished in *vret* germline and somatic mutant clones throughout oogenesis ([Fig. 4A-B′](#F4){ref-type="fig"}; see Fig. S3A in the supplementary material). Aub expression was severely reduced ([Fig. 4C-C′](#F4){ref-type="fig"}) and nuage localization was affected in mutant germline cells (see Fig. S3B in the supplementary material). By contrast, no significant change in AGO3 expression was observed ([Fig. 4D-D′](#F4){ref-type="fig"}) although the intracellular localization of AGO3 appeared punctate (see Fig. S3C in the supplementary material).

![***vret* is required for suppressing transposon expression in both the germline and somatic cells of the ovary.** (**A**) A weak *vret* allelic combination, *vret^39^/Df*, shows germline differentiation defects and abnormal somatic morphology. (**B**) *flam^BG^/flam^KG^* mutants show defective germline and soma differentiation phenotypes, similar to *vret* mutants. (**C**,**D**) In *flam^BG^/flam^KG^* mutant ovaries, somatic cells die as revealed by Caspase-3, compared with *flam* heterozygotes. (**E**,**F**) Cell death is also detected in *piwi^1^/piwi^2^* mutant ovaries. (**G**,**H**) *gypsy* expression is silenced in *vret* heterozygote (G), whereas in *vret* mutants (H), *gypsy* is derepressed in somatic cells, marked by β-gal. (**I**) Venn diagram showing overlap between transposable elements regulated in *vret, piwi* and *aub* mutant ovaries. (**J**) Profile of transposons regulated in *vret* mutant ovaries compared with *piwi* and *aub* mutant ovaries, shown as a heat map. All homozygous or transheterozygous mutant samples were normalized to their respective heterozygotes. Note that for some transposons, more than one probe was represented on the microarray (indicated with a superscript number).](DEV069187F3){#F3}

Consistent with the clonal analysis, Piwi and Aub protein levels were reduced in western blots whereas AGO3 protein remained at wild-type levels ([Fig. 4E](#F4){ref-type="fig"}). Protein expression of two other piRNA pathway components, Armitage (Armi) and Vasa, were unaffected by loss of *vret* ([Fig. 4E](#F4){ref-type="fig"}). Together, these results demonstrate that *vret* is required specifically for proper localization and accumulation of Piwi and Aub protein.

Vret associates with Piwi proteins in the ovary {#S20}
-----------------------------------------------

To determine whether Vret affects Piwi and Aub at the transcriptional level, we analyzed tagged *piwi* and *aub* transgenes under the control of the heterologous UASp promoter, driven by *nos-Gal4-VP16* to achieve germline expression. Transgenic Piwi and Aub proteins, revealed by Hemagglutinin (HA) and GFP staining, respectively, as well as endogenous protein levels were severely diminished in *vret* mutants ([Fig. 5A-D](#F5){ref-type="fig"}), demonstrating that Vret is not required for *piwi* and *aub* transcription but is somehow involved in post-transcriptional stability of these proteins.

![***vret* is required for Piwi and Aub protein accumulation.** (**A-D**′) *vret ^148-60^* germline and somatic mutant clones were generated at L3 and marked by the absence of GFP. (A-B′) Germline and somatic Piwi protein expression is dramatically reduced in *vret* mutant clones. (B-B′) An egg chamber with all follicle cells mutant for *vret* shows a dramatic reduction in somatic Piwi expression (outlined). (C-C′) Aub germline expression is severely affected in *vret* germline clones, whereas AGO3 expression (D-D′) is unchanged. GFP and the proteins tested are shown in separate channels for clarity. (**E**) Protein levels of Vret, Piwi, Aub, AGO3, Armi and Vasa are shown for wild-type (*w^1118^*), *vret^148-60^/TM6* and *vret^148-60^* mutant ovaries. α-Tubulin was used as loading control.](DEV069187F4){#F4}

To assess whether Vret is in a complex with Piwi or Aub we immunoprecipitated Vret from ovaries and probed lysates with antibodies against piRNA pathway components. We found that Vret specifically associates with Piwi and Aub ([Fig. 5E](#F5){ref-type="fig"}). Vret also interacts with Armi and weakly with AGO3 ([Fig. 5E](#F5){ref-type="fig"}). Although we observed a specific interaction between Vret and the piRNA components tested, it is unclear whether they are part of the same or separate complexes.

Piwi localizes to the nucleus ([@R9]), whereas Aub is cytoplasmic and associates with the perinuclear nuage ([@R23]). Vret protein expressed from a *UASp-vret-myc* transgene appeared cytoplasmic (see Fig. S4A-D in the supplementary material). To identify the cellular compartment in which Vret, Piwi and Aub might interact, we performed subcellular fractionations. In these experiments, the cytosolic and nuclear fractions of ovarian lysates were separated by differential centrifugation ([Fig. 5F](#F5){ref-type="fig"}). In *vret* heterozygous extracts, Vret appeared in the cytosolic fraction, marked by Orb, where it presumably associates with Aub ([Fig. 5F](#F5){ref-type="fig"}). Piwi was found predominantly in the nuclear fraction, marked by Fibrillarin, and at lower levels in the cytoplasm ([Fig. 5F](#F5){ref-type="fig"}), where it is most likely to interact with Vret. Piwi protein is thought to translocate to the nucleus once it is associated with piRNAs ([@R53]). By fractionating *vret* mutant ovarian extracts we found that the nuclear fraction of Piwi is affected more strongly than the cytoplasmic fraction ([Fig. 5F](#F5){ref-type="fig"}). Since Vret is cytoplasmic, these findings suggest that Vret association with Piwi might facilitate the translocation of Piwi to the nucleus.

Piwi stabilization is regulated uniquely in the gonad {#S21}
-----------------------------------------------------

To determine whether Vret has a general role in Piwi translation or stability or it is specifically required for Piwi protein stability in the gonad, we ectopically expressed Vret and Piwi in the dorsal domain of the *Drosophila* wing disc, where neither is normally expressed (see Fig. S5A′ in the supplementary material). In this heterologous tissue, Piwi protein, expressed as a *UASp-HA-piwi* transgene, was stable in the absence of Vret (see Fig. S5C-C′ in the supplementary material). *UASp-vret-myc* transgenic expression alone was unable to induce Piwi expression, supporting the notion that *piwi* is not regulated by Vret transcriptionally or translationally (see Fig. S5B-B′ in the supplementary material). Furthermore, the expression of a *UASp-vret-myc* transgene together with *UASp-HA-piwi* did not result in an increase of Piwi levels (see Fig. S5D-D′′ in the supplementary material). These results contrast with the loss of Piwi protein in the absence of Vret in the gonad, arguing that somatic and germline cells of the gonad employ a unique surveillance pathway regulating Piwi protein stability.

![**Vret interacts physically with Piwi proteins and regulates their stability.** (**A-D**) Post-transcriptional effects of Vret on Piwi and Aub proteins tested by expression of *piwi* and *aub* transgenes containing the UASp heterologous promoter. (A,C) Piwi and Aub proteins were expressed from *UASp-HA-piwi* and *UASp-aub-gfp* transgenes, respectively, in the germline. (B,D) Piwi and Aub protein levels are strongly reduced in *vret* mutant ovaries, shown by endogenous and transgenic expressions. (**E**) Physical interaction of Vret with piRNA components. *nos-Gal4-VP16* was used to express a *UASp-vret-myc* transgene and immunoprecipitation performed with Vret in ovarian lysates using an anti-Myc antibody. β-Tubulin was used as control. (**F**) Ovarian cell compartments can be separated by subcellular fractionation. Fibrillarin, a nuclear marker, and Orb, a cytoplasmic marker, were used as controls for efficient fraction separation. Homogenate (H), cytosolic (C) and nuclear (N) fractions are indicated. In *vret^148-60^* heterozygous ovaries, Vret appears in the cytosolic fraction whereas Piwi localizes to both nuclear and cytosolic fractions. In *vret* homozygotes, Piwi nuclear fraction is more affected than the cytosolic one.](DEV069187F5){#F5}

Primary piRNA production relies on Vret {#S22}
---------------------------------------

Our data show that Vret is required for Piwi and Aub stabilization, as well as transposon control, suggesting a possible role for Vret in piRNA regulation. To determine which aspect of the piRNA pathway Vret affects, we cloned and sequenced 19-29 nt small RNAs from *vret* heterozygous and homozygous ovaries, and normalized libraries to the number of gene-derived, antisense-mapping endo-siRNAs as previously described ([@R2]) (see Materials and methods). To account for degraded RNA contamination, when possible, we analyzed small RNAs mapping antisense to active transposons, which would probably be derived from an active processing mechanism ([@R34]). We found that small RNAs in the piRNA range (23-29 nt) were dramatically diminished ([Fig. 6A](#F6){ref-type="fig"}). In contrast to piRNAs, we found that overall levels of siRNAs (20-22 nt) were increased. This change can, however, be almost entirely attributed to a striking increase in siRNAs derived from a single retrotransposon, MDG1 (from 0.6% to 44.2% of total siRNAs in *vret* heterozygotes compared with mutants, respectively) ([Fig. 6A](#F6){ref-type="fig"}). The specificity of MDG1 suggests that the increase in MDG1-derived siRNAs is a product of MDG1 de-repression in the absence of piRNA silencing, rather than a more direct effect of Vret on the endo-siRNA pathway.

As piRNA clusters are the primary source of transposon-targeting piRNAs, we analyzed changes in piRNAs mapping uniquely to the genome, ensuring that they were in fact derived from the corresponding cluster ([Fig. 6B,C](#F6){ref-type="fig"}). We found that piRNAs from germline (42AB and Cluster 3) and soma (*flam* and *traffic jam*) as well as clusters expressed in both tissues (Cluster 2) were dramatically reduced in the absence of *vret* ([Fig. 6B,C](#F6){ref-type="fig"}).

As piRNAs bound to Piwi, Aub and AGO3 are of different average sizes ([@R2]) ([Fig. 6D](#F6){ref-type="fig"}), changes in piRNA sizes can be used to determine whether Piwi-, Aub- or AGO3-bound piRNAs are differentially affected in *vret* mutants. To illustrate this point, in *aub* or *piwi* mutant ovaries, piRNAs increase or decrease in size, respectively, compared with heterozygous controls for two prototypic germline-regulated transposons, *Batumi* and *Roo* ([Fig. 6E](#F6){ref-type="fig"}). In *vret* mutants, we observed a decrease in piRNA size compared with heterozygotes ([Fig. 6E](#F6){ref-type="fig"}), indicating a preferential loss of Piwi-bound piRNAs and a shift towards Aub and AGO3.

Aub and AGO3 have been implicated in \`ping-pong\', an amplification cycle that generates piRNAs with a 5′ complementarity between antisense and sense piRNAs. We therefore investigated whether loss of Vret affected the ability of Aub and AGO3 per se to participate in \`ping-pong\'. To do this, we measured the 5′ complementarity of piRNAs matching individual transposons, with an expected 10 nt overlap due to slicer cleavage, as previously reported ([@R3]). Focusing on the *Batumi* and *Roo* transposons, we observed that primary piRNAs were preferentially lost in *vret* mutants, almost exclusively leaving 10 nt offset \`ping-pong\' pairs in *vret* mutant ovaries ([Fig. 6F,G](#F6){ref-type="fig"}); this is similar to observations in *armi* and *piwi* mutants, and in contrast to *aub* mutants, which affect \`ping-pong\' amplification ([Fig. 6F](#F6){ref-type="fig"}) ([@R34]; [@R42]). Together, these results indicate that Vret plays an essential role upstream of Piwi, and possibly Aub, in the primary piRNA pathway. Additionally, piRNA loss is most likely to underlie the transposon silencing defects observed in *vret* mutants.

![**Vret is required for primary piRNA biogenesis.** (**A**) piRNA production is reduced in *vret* mutant ovaries. Size profiles of \`repeat, antisense mapping\' annotated small RNAs from *vret^148-60^* heterozygous and *vret^148-60^* homozygous ovaries are shown. Note that increase in siRNAs derives from the transposon *mdg1* (light red) (for explanation, see text). (**B**,**C**) piRNAs generated from both germline and somatic-expressed clusters are severely reduced in *vret* mutant ovaries. (B) Density map showing normalized peaks of genome-unique piRNAs from *vret* heterozygote and mutant ovarian small RNA libraries across the 42AB (also called Cluster 1) and *flam* piRNA clusters. (C) Cluster-derived, normalized, genome-unique piRNAs remaining in *vret* mutant ovarian libraries, shown as a percentage of normalized *vret* heterozygote levels. Clusters are indicated by their cytological band location, their name, and predominant expression in either \`germline\', \`soma\' or \`both\' types of ovarian tissues. (**D**) Size distribution of piRNAs bound by Piwi proteins. (**E**) Piwi-bound piRNAs are preferentially lost in *vret* mutant ovaries. The change in average size of ovarian, transposon-derived piRNAs, due to mutation in either *aub* (*aub^HN2^/aub^QC42^*), *piwi* (*piwi^1^/piwi^2^*)or *vret* (*vret^148-60^*) is shown. Individual *aub, piwi* or *vret* heterozygote libraries were used to determine wild-type average piRNA size. (**F**) piRNA \`ping-pong\' signal, indicated by a peak at 10 nt, from 23-29 nt reads mapping to the *Batumi* and *Roo* transposons in *aub, piwi* or *vret* mutant ovarian small RNA libraries. (**G**) Density map showing normalized peaks of piRNAs from *vret* heterozygote or mutant ovarian small RNA libraries, with sense mappers above the *x*-axis and antisense below. Close-ups show the remaining piRNA \`ping-pong\' peaks (green arrows) in *vret* mutant ovaries compared with heterozygotes.](DEV069187F6){#F6}

Vret does not affect piRNA cluster transcription {#S23}
------------------------------------------------

To determine whether piRNA cluster transcription was affected in *vret* mutants, we analyzed the steady-state RNA levels of *Drosophila* piRNA clusters by qPCR. We focused on the uni-strand-transcribed, somatic *flam* cluster and the dual-strand-transcribed, germline 42AB cluster (see Fig. S6 in the supplementary material). Ovaries mutant for *rhino* (*rhi*), which is required for cluster 42AB transcription ([@R28]), and for *flam*, in which *flam* transcript is undetected ([@R2]), were used as controls (see Fig. S6C,D in the supplementary material). In contrast to these controls, *vret* mutants showed no change in transcription from both the 42AB and *flam* clusters compared with heterozygotes (see Fig. S6A,B in the supplementary material), suggesting that Vret does not affect piRNA cluster transcription.

DISCUSSION {#S24}
==========

We identified a novel protein with critical roles in oocyte polarity, germline and soma differentiation, survival and transposon control. Vret, a Tudor-domain containing protein, associates with Piwi proteins in the cytoplasm of *Drosophila* ovarian cells and regulates their stability, as well as Piwi nuclear localization and localization of Aub to nuage. In the absence of Vret, piRNAs are dramatically reduced and transposons mobilized. By ordering the function of Vret within the network of the piRNA-transposon-based system, we conclude that Vret functions in primary piRNA biogenesis at the stage of primary piRNA loading onto Piwi and Aub complexes.

Loss of Vret in the soma or germline has strikingly different morphological consequences. Our molecular analysis, however, suggests the same underlying cause for these defects: a failure to produce biologically active piRNAs. Morphologically, the *vret* germline phenotype resembles that of mutants defective in germline piRNA biogenesis, such as *aub, spnE* and *krimper* ([@R18]; [@R31]; [@R65]). In these mutants, transposon mobilization activates a DNA damage checkpoint that leads to defects in transport and translation of maternal RNAs necessary for oocyte polarity and embryonic patterning ([@R5]; [@R15]; [@R27]; [@R31]; [@R39]). Interestingly, lack of *vret* in the soma resembles the *piwi* mutant phenotype, in which GSCs fail to differentiate as a consequence of somatic cell death, an event presumably associated with transposon misregulation. Thus, loss of *vret* in the germline and gonadal soma resembles loss of both Piwi and Aub. This, together with our findings that Vret associates with Piwi and Aub in ovarian extracts and affects the stability of both, strongly suggests that Vret regulates both proteins in a similar fashion.

Surprisingly, Vret is not required for piRNA \`ping-pong\' amplification per se, suggesting that Vret might selectively interact with Aub and Piwi bound to primary piRNAs and not to those engaged in \`ping-pong\'. In this scenario, it would be possible for maternally deposited Aub to initiate the \`ping-pong\' cycle with AGO3, even in the absence of Vret ([@R3]). As some Aub protein remains in *vret* mutant ovaries, an active pool of Vret-independent Aub could maintain \`ping-pong\' activity throughout the adult ovary. Therefore, we propose that a \`ping-pong\'-independent pool of Aub within the cytoplasm depends upon primary piRNA loading, downstream of Vret function. It would be interesting to examine whether piRNAs associated with the Vret-dependent complex can, at any level, contribute to \`ping-pong\', or whether Aub-bound primary piRNAs are functionally or enzymatically distinct from those involved in the piRNA amplification cycle.

In contrast to Aub, only a small subset of Piwi-bound piRNAs showed a 10 nt overlap with those bound to AGO3. Indeed, Piwi is genetically dispensible for \`ping-pong\' and might be only marginally involved in \`ping-pong\', if at all ([@R2]; [@R30]). As Piwi slicer activity does not appear to be required for Piwi function ([@R53]), it seems most plausible that Piwi would act as a recipient, and not as an \`active\' component of \`ping-pong\' amplification. Regardless, the majority of Piwi-bound primary piRNAs act independently of \`ping-pong\' and depend upon Vret for stability.

Our ectopic expression experiment suggests that Piwi is not \`intrinsically unstable\', but becomes unstable in the gonad in the absence of Vret. Furthermore, Vret is not required for Piwi or Aub transcription or translation. Vret, therefore, could either coordinate the process of biogenesis and loading of primary piRNAs into Piwi and Aub complexes or be involved in stabilizing the mature RISC (RNA-induced silencing complex). Armi, a putative helicase, and Zucchini (Zuc), a member of the phospholipase D (PLD) family of phosphodiesterases, act like Vret in the soma and germline; they specifically affect Piwi protein stability and primary piRNA levels leaving the \`ping-pong\' cycle intact ([@R22]; [@R34]; [@R42]; [@R43]; [@R54]). Unlike Vret, the levels of unprocessed precursor RNA from *flam* are increased in *zuc* mutants implicating Zuc in piRNA cluster transcript processing. We therefore favor the hypothesis that Vret, possibly together with Armi, is an essential component of Piwi and Aub RISC complexes. Vret is one of many Tudor domain proteins in *Drosophila* that affects piRNA biogenesis and contains conserved residues that are known to be required for binding of sDMAs found in Piwi proteins ([@R57]). When mutated, each of these genes displays a rather distinct phenotype. Krimper and SpnE regulate transposon levels in the germline whereas fs(1)Yb is soma-specific. Vret is, at this point, the only Tudor domain protein known to be required in both tissues, suggesting a conserved and global role for this gene in piRNA regulation. It remains to be determined whether the mammalian Tudor homolog could fulfill a similar function.
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